Specialty Pharma Journal Specialty, Precision & Technology
BRIDGEWATER, N.J., Aug. 3, 2018 /PRNewswire/ — Salix Pharmaceuticals, a leading specialty pharmaceutical company committed to the prevention and treatment of gastrointestinal (GI) disorders and a wholly owned subsidiary of Bausch Health Companies Inc. (NYSE/TSX: BHC), today announced its affiliate has entered into a research agreement with Cedars-Sinai Medical Center …
Tag Archives: salix pharmaceuticals
August, 2018
March, 2015
-
16 March
Valeant Raises its Offer to Acquire Salix
After Endo International offered a rival bid, Valeant Pharmaceuticals International announced that it has raised its offer for gastrointestinal drugmaker Salix Pharmaceuticals. The companies announced that they have entered into an amendment to their agreement and plan merger. Valeant has increased its offer price to acquire all the outstanding common …
-
11 March
Endo Threatens Valeant’s Deal with Competing Bid for Salix Pharmaceuticals
Today, Endo International plc confirmed that it has made a takeover bid for Salix Pharmaceuticals Ltd., looking to interrupt Valeant’s plans to acquire the gastrointestinal drugmaker. Endo said that it has submitted a proposal to the Board of Directors of Salix to acquire all of the outstanding shares of common …
February, 2015
-
23 February
Valeant to Buy Salix Pharmaceuticals for $10.1 Billion
Valeant Pharmaceuticals International Inc. announced that it is buying Salix Pharmaceuticals Ltd. for $10.1 billion. Valeant is paying $158 a share for Salix, gaining a portfolio of gastrointestinal (GI) drugs and a strong near-term pipeline of innovative, new assets. The deal values Salix at about $14.5 billion including net debt …